The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Intergration of common clinical and laboratory parameters for predictive modeling of outcome with immune checkpoint inhibitors (ICIs) in patients (pts) with Nnon-small cell lung cancer (NSCLC).
 
Konstantinos Rounis
Travel, Accommodations, Expenses - Astellas Pharma; MSD; Teva
 
Dimitrios Makrakis
No Relationships to Disclose
 
Chara Papadaki
No Relationships to Disclose
 
Alexia A Monastirioti
No Relationships to Disclose
 
Lampros Vamvakas
No Relationships to Disclose
 
Kostas Kalbakis
No Relationships to Disclose
 
Krystallia Gourlia
No Relationships to Disclose
 
Iordanis Xanthopoulos
No Relationships to Disclose
 
Dimitrios Mavroudis
Employment - Vifor Pharma (I)
Consulting or Advisory Role - MSD; Roche
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genesis Pharmaceuticals; Roche
 
Sofia Agelaki
No Relationships to Disclose